• Medpace Holdings General Counsel and Corporate Secretary Stephen P. Ewald sold 1,245 shares of common stock.
• The sale occurred Oct. 29, 2026, at $690 per share.
• Ewald directly owned 19,098 shares following the transaction, according to the Form 4 dated Nov. 2, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001677297-26-000008), on November 02, 2026, and is solely responsible for the information contained therein.